EVALUATION OF SOLUBILIZERS IN THE DRUG-RELEASE TESTING OF HYDROPHILIC MATRIX EXTENDED-RELEASE TABLETS OF FELODIPINE

被引:58
作者
ABRAHAMSSON, B
JOHANSSON, D
TORSTENSSON, A
WINGSTRAND, K
机构
[1] Pharmaceutical R&D, Astra Hässle, Mölndal
关键词
FELODIPINE ER; HYDROPHILIC MATRIX TABLETS; SOLUBILIZERS; IN VITRO DRUG RELEASE; IN VITRO IN VIVO CORRELATION;
D O I
10.1023/A:1018920412020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The drug release of felodipine, a water-insoluble drug, was tested by using sodium lauryl sulphate (SLS), polyoxyethylene 20 sorbitan monooleate (Tween) or cetyltrimethylammonium bromide (CTAB) in the test medium as solubilizers. Three slightly different felodipine extended-release (ER) tablets 10 mg based on the gel matrix principle were evaluated under different solubilizer concentrations, agitation intensities and pH. These tablets were also tested in a bioavailability study together with an oral solution. All three solubilizers substantially enhanced the drug solubility and sink conditions were obtained. The choice of solubilizer affected the drug release rate. This is most probably due to physico-chemical interactions between the gel-forming agent and the solubilizers. All in vitro test conditions provided a good correlation (r(2) = 0.94-0.97) to in vivo dissolution, as determined by moment analysis. However, a much steeper in vitro/in vivo relationship was obtained for SLS compared to Tween and CTAB reflecting an inferior discrimination between the tablets by use of this anionic solubilizer.
引用
收藏
页码:1093 / 1097
页数:5
相关论文
共 11 条
[1]  
Ahnoff M, 1984, J Pharm Biomed Anal, V2, P519, DOI 10.1016/0731-7085(84)80055-2
[2]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[3]   PLASMA-CONCENTRATION PROFILES AND ANTIHYPERTENSIVE EFFECT OF CONVENTIONAL AND EXTENDED-RELEASE FELODIPINE TABLETS [J].
BLYCHERT, E ;
WINGSTRAND, K ;
EDGAR, B ;
LIDMAN, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (01) :39-45
[4]   FELODIPINE CLINICAL PHARMACOKINETICS [J].
DUNSELMAN, PHJM ;
EDGAR, B .
CLINICAL PHARMACOKINETICS, 1991, 21 (06) :418-430
[5]   ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[6]  
LANGENBUCHER F, 1982, PHARM IND, V44, P1166
[7]  
LOFROTH JE, 1991, HPMC PROGR COLLOID P, V84, P1
[8]   THE APPLICATION OF STATISTICAL MOMENT THEORY TO THE EVALUATION OF INVIVO DISSOLUTION TIME AND ABSORPTION TIME [J].
RIEGELMAN, S ;
COLLIER, P .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :509-534
[9]  
Shah V.P., 1989, PHARM RES-DORDR, V6, P162
[10]  
VONHATTINGBERG HM, 1984, METHOD FIND EXP CLIN, V6, P589